An internal standard for the quantification of flumequine
Related Products
Unlabeled Version(s)
21645Flumequine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Flumequine-13C3

Item No. 34006

Technical Information
Formal Name
9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic-1,2-13C2 acid-13C
CAS Number
1185049-09-5
Synonyms
  • (±)-Flumequine-13C3
  • R-802-13C3
Molecular Formula
C11[13C]3H12FNO3
Formula Weight
Purity
≥98%
A solid
Acetonitrile:Methanol (1:1): solubleDMSO: soluble
SMILES
O=[13C]1C2=CC(F)=CC3=C2N(C(CC3)C)C=[13C]1[13C](O)=O
InChi Code
InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)/i11+1,13+1,14+1
InChi Key
DPSPPJIUMHPXMA-AIGZGMKWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Flumequine-13C3 is intended for use as an internal standard for the quantification of flumequine (Item No. 21645) by GC- or LC-MS. Flumequine is a fluoroquinolone antibiotic.1 It is active against S. aureus, S. pyogenes, B. subtilis, E. coli, P. aeruginosa, S. faecalis, and K. pneumoniae (MICs = 1-100 µg/ml). Flumequine is also active against field isolates of B. hyodysenteriae (MICs = 6.25-200 µg/ml).2 It inhibits DNA gyrase, disrupting supercoiling of bacterial DNA to block transcription and replication.3 In vivo, flumequine (50 mg/kg) increases survival in rat models of P. vulgaris-induced urinary tract infection and P. mirabilis-induced prostatitis.1 Formulations containing flumequine have been used in the treatment of urinary tract infections in veterinary medicine.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rohlfing, S.R., Gerster, J.R., and Kvam, D.C. Bioevaluation of the antibacterial flumequine for urinary tract use. Antimicrob. Agents Chemother. 10(1), 20-24 (1976).

    2. Aller-Morán, L.M., Martínez-Lobo, F.J., Rubio, P., et alEvaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae. Res. Vet. Sci. 103, 51-53 (2015).

    3. Smith, J.T. The mode of action of 4-quinolones and possible mechanisms of resistance. J. Antimicrob. Chemother. 18 (Suppl. D), 21-29 (1986).